Inhibition of STAT3 has been reported to reduce eosinophilic infiltration, cytokine release, and airway hyperresponsiveness in asthma models, while also attenuating IL-6-mediated inflammatory signaling and airway remodeling in COPD [34,35,36]. Here, STAT3 is linked to asthma.